<pages><page bbox="0.000,0.000,720.000,540.000" id="1" rotate="0">
<normal_text archetypal_index="0" bbox="131.710,267.980,606.809,493.649" id="0" size="24.006" Annotation_index="0">Testimony of Sidney M. Wolfe MD 
and Elizabeth Barbehenn, Ph.D.,  
Public Citizen&#8217;s Health Research Group 
FDA Non-Prescription and Endocrine 
and Metabolic Drug Advisory Committees 
Hearing on Possible Switch of  
Orlistat to OTC Status 
January 23, 2006 <textline bbox="175.300,469.625,556.633,493.649" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.024">Testimony of Sidney M. Wolfe MD </textline>
<textline bbox="182.140,440.810,556.564,464.810" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.000">and Elizabeth Barbehenn, Ph.D.,  </textline>
<textline bbox="141.070,412.010,590.734,436.010" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.000">Public Citizen&#8217;s Health Research Group </textline>
<textline bbox="154.510,383.210,577.396,407.210" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.000">FDA Non-Prescription and Endocrine </textline>
<textline bbox="131.710,354.405,606.809,378.429" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.024">and Metabolic Drug Advisory Committees </textline>
<textline bbox="197.500,325.580,547.780,349.580" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.000">Hearing on Possible Switch of  </textline>
<textline bbox="240.820,296.780,491.236,320.780" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.000">Orlistat to OTC Status </textline>
<textline bbox="269.980,267.980,461.980,291.980" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="24.000">January 23, 2006 </textline>
</normal_text>
<title archetypal_index="1" bbox="88.032,115.717,667.123,224.562" id="1" size="32.048" Annotation_index="1">Principles to Consider When Deciding 
on an Rx-to-OTC Switch: 
Application in the Case of Orlistat <textline bbox="88.032,192.522,667.123,224.562" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="32.040">Principles to Consider When Deciding </textline>
<textline bbox="193.630,154.122,570.285,186.162" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="32.040">on an Rx-to-OTC Switch: </textline>
<textline bbox="120.910,115.717,634.062,147.781" colourspace="DeviceGray" font="Arial-BoldMT" ncolour="1" size="32.064">Application in the Case of Orlistat </textline>
</title>
</page>
</pages>